Coloplast A/S CLPBF
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 3.28% | -0.91% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 3.28% | -0.91% | |||
| Cost of Revenue | 2.84% | 1.03% | |||
| Gross Profit | 3.50% | -1.86% | |||
| SG&A Expenses | 1.60% | -0.67% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -8.13% | -277.63% | |||
| Total Operating Expenses | 2.54% | -0.14% | |||
| Operating Income | 5.43% | -3.08% | |||
| Income Before Tax | 249.85% | -168.43% | |||
| Income Tax Expenses | 250.13% | -168.26% | |||
| Earnings from Continuing Operations | 249.78% | -168.47% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 249.78% | -168.47% | |||
| EBIT | 5.43% | -3.08% | |||
| EBITDA | 142.71% | -2.65% | |||
| EPS Basic | 249.77% | -168.41% | |||
| Normalized Basic EPS | 5.67% | -4.00% | |||
| EPS Diluted | 249.72% | -168.51% | |||
| Normalized Diluted EPS | 5.67% | -4.00% | |||
| Average Basic Shares Outstanding | 0.00% | 0.09% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.09% | |||
| Dividend Per Share | -100.00% | -- | |||
| Payout Ratio | -- | -1.00% | |||